These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15744786)

  • 21. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
    Raymond VM; Everett JN
    Best Pract Res Clin Gastroenterol; 2009; 23(2):275-83. PubMed ID: 19414152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Information spreading about hereditary carriage of a BRCA1/2 mutation and ovarian cancer and rate of consultation of the concerned relatives].
    Christophe V; Leroy T; Adenis C; Reich M; Vennin P
    Bull Cancer; 2008 Apr; 95(4):395-402. PubMed ID: 18495568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective.
    Kasparian NA; Butow PN; Meiser B; Mann GJ
    Psychooncology; 2008 Mar; 17(3):270-9. PubMed ID: 17600854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
    Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
    Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of familial melanoma and nonmelanoma skin cancer syndromes.
    Santillan AA; Cherpelis BS; Glass LF; Sondak VK
    Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of psychological distress among individuals with a strong family history of malignant melanoma.
    Kasparian NA; Meiser B; Butow PN; Simpson JM; Mann GJ
    Clin Genet; 2008 Feb; 73(2):121-31. PubMed ID: 18177469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal counseling--implications of the cultural background of pregnant women on information processing, emotional response and acceptance.
    Tschudin S; Huang D; Mor-Gültekin H; Alder J; Bitzer J; Tercanli S
    Ultraschall Med; 2011 Dec; 32 Suppl 2():E100-7. PubMed ID: 22187410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Areas of intervention for genetic counselling of dementia: cross-cultural comparison between Italians and Americans.
    Binetti G; Benussi L; Roberts S; Villa A; Pasqualetti P; Sheu CF; Gigola L; Lussignoli G; Dal Forno G; Barbiero L; Corbellini G; Green RC; Rossini PM; Ghidoni R
    Patient Educ Couns; 2006 Dec; 64(1-3):285-93. PubMed ID: 16860519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study.
    Meiser B; Mitchell PB; McGirr H; Van Herten M; Schofield PR
    Soc Sci Med; 2005 Jan; 60(1):109-18. PubMed ID: 15482871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis.
    Applebaum-Shapiro SE; Peters JA; O'Connell JA; Aston CE; Whitcomb DC
    Am J Gastroenterol; 2001 May; 96(5):1610-7. PubMed ID: 11374708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.
    Geller AC; Emmons KM; Brooks DR; Powers C; Zhang Z; Koh HK; Heeren T; Sober AJ; Li F; Gilchrest BA
    Cancer; 2006 Aug; 107(4):806-14. PubMed ID: 16832795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived genetic knowledge, attitudes towards genetic testing, and the relationship between these among patients with a chronic disease.
    Morren M; Rijken M; Baanders AN; Bensing J
    Patient Educ Couns; 2007 Feb; 65(2):197-204. PubMed ID: 16939709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
    Collins V; Meiser B; Gaff C; St John DJ; Halliday J
    Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
    Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
    Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.